Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Neoplasms × relugolix × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 27 Leiomyoma 9 Endometriosis 4 Myofibroma 3 Menorrhagia 3 Pregnancy Complications 2 Adenocarcinoma 2 Uterine Neoplasms 1 Uterine Hemorrhage 1 Prostate Adenocarcinoma 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Myoma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-Resistant Prostate Cancer 1

Interventions

Paclitaxel 12 pembrolizumab 8 Carboplatin 7 Surveys and Questionnaires 5 Docetaxel 4 Cisplatin 4 Brachytherapy 4 Gemcitabine 3 FANG vaccine 3 Doxorubicin 3 olaparib 2 durvalumab 2 Topotecan 2 Sentinel Lymph Node Biopsy 2 Saline Solution 2 Radiotherapy 2 Radiation 2 Pemetrexed 2 Music Therapy 2 Letrozole 2 Imagery, Psychotherapy 2 Hysterectomy 2 Exercise 2 CP protocol 2 Bevacizumab 2 ulipristal acetate 1 trastuzumab deruxtecan 1 temsirolimus 1 seribantumab 1 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06953076 2025-08-17

MySaturn

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Leiomyoma, Myoma, Uterine Hemorrhage, Uterine Neoplasms, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡